Hypromellose
This medicine should always be used exactly as described in the patient leaflet or as directed by your doctor or pharmacist.
Artelac is an eye drop solution. The active substance is hypromellose.
Artelac is used for the symptomatic treatment of dry eye syndrome. Dry eye syndrome may occur when there is a deficiency in tear production or when the eyelids cannot be fully or partially closed.
The medicine may also be used to moisten hard contact lenses.
If you do not feel better or if you feel worse, you should contact your doctor.
One in five patients treated by an ophthalmologist has symptoms of dry eye syndrome. There are many causes of this condition, such as decreased tear production in older age, working in an air-conditioned room, working on a computer, hormonal changes during menopause, etc. Environmental pollution and climate can also play a role in the development of dry eye syndrome.
During the day, we blink our eyelids about 14,000 times. With each blink, a very thin layer of tears is spread over the surface of the eyeball, maintaining smoothness, cleanliness, and moisture, and protecting against environmental pollutants. If the amount or composition of the tear fluid is disturbed, the cornea and conjunctiva dry out, causing symptoms such as burning, feeling of dryness, feeling of sand in the eye, feeling of pressure, and sensitivity to light.
Before starting to use Artelac, you should discuss it with your doctor or pharmacist:
You should tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
Interactions with other medicines are not known.
If Artelac is used with other eye medicines, you should wait 15 minutes between applications. Artelac should always be administered last, after 15 minutes from the application of another medicine, to ensure sufficient time for the moisturizing effect of Artelac.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.
Artelac should not be used during pregnancy and breastfeeding, unless your doctor decides otherwise.
Artelac may cause temporary blurred vision after application. You should not drive or operate machinery until your vision is clear.
Artelac contains cetrimide as a preservative.It may cause eye irritation (burning, redness, feeling of a foreign body) and damage to the corneal epithelium, especially with long-term use.
Therefore, for long-term or continuous treatment of dry eye syndrome, preservative-free medicines are recommended.
(1 ml of solution contains 1.84 mg of phosphates).
In patients with severe damage to the transparent, anterior part of the eye (cornea), phosphates may rarely cause corneal clouding due to calcium deposition during treatment.
This medicine should always be used exactly as described in the patient leaflet or as directed by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist.
Recommended dose
Treatment of dry eye syndrome requires individual dosing.
Depending on the severity and frequency of symptoms, usually one drop is instilled into the conjunctival sac 3 to 5 times a day, or more often if needed.
You should consult your ophthalmologist if you need long-term or continuous treatment with Artelac.
The medicine can also be used to moisten hard contact lenses.
To avoid contamination of the eye drops, do not touch the dropper tip with your fingers or touch it to the eye or any other surface. Using contaminated drops can lead to serious eye damage, including vision loss.
6. Bring the dropper tip close to the eye, without touching the eye, eyelid, or surrounding areas.
Having someone else help you or using a mirror can make it easier to administer the medicine.
If you feel that the effect of Artelac is too strong or too weak, you should consult your doctor or pharmacist.
If you accidentally use more than the recommended dose, it may cause blurred vision, which will clear up quickly.
If you miss a dose, take the next dose at the usual time, as directed. Do not take a double dose to make up for the missed dose.
If you have any further questions about using this medicine, ask your doctor or pharmacist.
Like all medicines, Artelac can cause side effects, although not everybody gets them.
The frequency of possible side effects is defined as follows:
The following side effects may occur:
Frequency not known:
If you experience any side effects, including those not listed in this leaflet, tell your doctor, pharmacist, or nurse.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181 C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Store in a temperature below 30°C.
Shelf life after first opening the bottle: 6 weeks.
Discard any unused contents of the pack after 6 weeks from first opening the bottle.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Artelac is an eye drop solution.
Available packs:
Bottle containing 10 ml of eye drops.
For more detailed information, contact the marketing authorization holder or the parallel importer.
BAUSCH + LOMB IRELAND LIMITED, 3013 Lake Drive, Citywest Business Campus, Dublin 24, D24PPT3, Ireland
Dr. Gerhard Mann Chem-Pharm Fabrik GmbH, Brunsbütteler Damm 165/173, D-13581 Berlin, Germany
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Netherlands, country of export, authorization number: RVG 32371
Parallel import authorization number:136/23
[Information about the trademark]
Page 5 of 5
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.